Hospital burden of Respiratory Syncytial Virus in children in Spain (2016-2022): A retrospective study

Ruth Gil-Prieto1, Rafael García-Carretero1, Valentín Hernandez-Barrera1

  • 1Medical Specialities and Public Health Department, Area of Preventive Medicine and Public Health, Rey Juan Carlos University, Madrid, Spain.

PubMed

Insights

Respiratory Syncytial Virus (RSV) causes significant hospitalizations in Spanish children, especially infants under one year old. Prevention strategies are crucial to reduce this pediatric burden and associated healthcare costs.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Respiratory Syncytial Virus (RSV) is a primary cause of severe respiratory infections in young children.
  • Infants and children under two years old are particularly vulnerable to RSV complications.

Purpose of the Study:

  • To quantify the population-based burden of RSV-related hospitalizations in Spain among individuals under 19 years from 2016 to 2022.
  • To analyze hospitalization rates, mortality, case fatality, and healthcare costs associated with RSV in different pediatric age groups.

Main Methods:

  • Retrospective analysis of national hospital discharge data in Spain (2016-2022).
  • Evaluation of hospitalization rates, mortality, case fatality, and costs stratified by age and year.
  • Analysis of the impact of comorbidities on case fatality rates.

Main Results:

  • Over 166,000 RSV hospitalizations occurred, predominantly in children under five (94.60%) and infants under one (66.22%).
  • Infants under one year had the highest hospitalization rate (4,367.87 per 100,000), peaking in 2022. Highest mortality was also in this group.
  • Comorbidities significantly increased case fatality in children under five (0.76% vs. 0.02%). RSV burden decreased during COVID-19 pandemic years.

Conclusions:

  • RSV represents a substantial public health burden on the pediatric population in Spain, with infants being the most affected.
  • The study highlights the significant economic impact, exceeding €497 million in total costs.
  • Effective preventive measures, including immunization and early interventions, are essential to mitigate RSV's impact on children.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
981
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.2K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
791
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
421
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
728
Respiratory Volumes and Capacities01:22

Respiratory Volumes and Capacities

The respiratory system is responsible for the intake of oxygen and the expulsion of carbon dioxide from the body. Respiratory volumes describe the volume of air in the lungs at different phases of the respiratory cycle. Tidal volume is the air breathed in and out during normal, quiet breathing. Inspiratory reserve volume is the air that can be forcefully inspired beyond the tidal volume. In contrast, expiratory reserve volume refers to the air that can be expelled from the lungs after a normal...
4.8K